Health

New Delhi, December 22 All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday said that

London, December 21 The protection offered by the Oxford-AstraZeneca Covid-19 vaccine, named Covishield in India, declines after three months of

New Deli, December 18 With increasing cases of COVID-19 Omicron variant in the country, Dr Puneet Misra, Professor of Community

New Delhi, December 17 As many as 101 cases of Omicron variant of COVID-19 so far have been detected across

New Delhi, December 14 Health Minister Mansukh Mandaviya has said that over 55 percent of the eligible population of the

New Delhi, December 14 The Centre has told the Delhi High Court that the National Technical Advisory Group of Immunization

Chandigarh, December 12 Chandigarh reported its first case of Omicron after swab samples of a fully vaccinated 20-year-old male passenger

By B.Maharana New Delhi, December 11 India’s cumulative COVID-19 vaccination coverage has reached over 133.92 crores doses. According to a

Dibrugarh, December 11 Amid rising cases of the new COVID-19 variant Omicron, the Indian Council of Medical Research (ICMR) in

New Delhi, December 09 AstraZeneca’s Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation